Pharmaron Beijing (3759) Schedules Extraordinary General Meeting, Seeks Director By-Election and Amendments to Governance Policies

Bulletin Express11-27

Pharmaron Beijing Co., Ltd. (stock code: 3759) has announced that its first Extraordinary General Meeting of 2025 will take place on Thursday, December 18, 2025 at 2:30 p.m., at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC.

Key items to be addressed include a proposed by-election of an independent non-executive director to replace the outgoing incumbent. The board prepared multiple motions on amendments to governing documentation, including the Articles of Association, procedural rules for general and board meetings, and several internal management policies. Topics cover adjustments to related party/connected transactions management, external guarantees, investment oversight, and proceeds usage.

The agenda also includes updates to the rules on implementing the cumulative voting mechanism and clarifications to the procedure for shareholder nominations of director candidates. These changes aim to strengthen compliance with applicable regulatory requirements and refine the Company’s internal governance processes. Shareholders of record on December 15, 2025 will be entitled to vote. The final voting results will be published after the EGM. The Company’s board encourages shareholders to review the detailed proposals in preparation for the meeting.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1111509776?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-27 16:43","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1111509776","market":"hk","top_or_hot":-1,"title":"Pharmaron Beijing (3759) Schedules Extraordinary General Meeting, Seeks Director By-Election and Amendments to Governance Policies","media":"Bulletin Express","content":"<p>Pharmaron Beijing Co., Ltd. (stock code: 3759) has announced that its first Extraordinary General Meeting of 2025 will take place on Thursday, December 18, 2025 at 2:30 p.m., at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC.</p>\n<p>Key items to be addressed include a proposed by-election of an independent non-executive director to replace the outgoing incumbent. The board prepared multiple motions on amendments to governing documentation, including the Articles of Association, procedural rules for general and board meetings, and several internal management policies. Topics cover adjustments to related party/connected transactions management, external guarantees, investment oversight, and proceeds usage.</p>\n<p>The agenda also includes updates to the rules on implementing the cumulative voting mechanism and clarifications to the procedure for shareholder nominations of director candidates. These changes aim to strengthen compliance with applicable regulatory requirements and refine the Company’s internal governance processes. Shareholders of record on December 15, 2025 will be entitled to vote. The final voting results will be published after the EGM. The Company’s board encourages shareholders to review the detailed proposals in preparation for the meeting.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Pharmaron Beijing (3759) Schedules Extraordinary General Meeting, Seeks Director By-Election and Amendments to Governance Policies</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPharmaron Beijing (3759) Schedules Extraordinary General Meeting, Seeks Director By-Election and Amendments to Governance Policies\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2025-11-27 16:43</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Pharmaron Beijing Co., Ltd. (stock code: 3759) has announced that its first Extraordinary General Meeting of 2025 will take place on Thursday, December 18, 2025 at 2:30 p.m., at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC.</p>\n<p>Key items to be addressed include a proposed by-election of an independent non-executive director to replace the outgoing incumbent. The board prepared multiple motions on amendments to governing documentation, including the Articles of Association, procedural rules for general and board meetings, and several internal management policies. Topics cover adjustments to related party/connected transactions management, external guarantees, investment oversight, and proceeds usage.</p>\n<p>The agenda also includes updates to the rules on implementing the cumulative voting mechanism and clarifications to the procedure for shareholder nominations of director candidates. These changes aim to strengthen compliance with applicable regulatory requirements and refine the Company’s internal governance processes. Shareholders of record on December 15, 2025 will be entitled to vote. The final voting results will be published after the EGM. The Company’s board encourages shareholders to review the detailed proposals in preparation for the meeting.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"03759","symbol_name":"康龙化成","start_time":0,"source_url":"","article_id":"1111509776","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1111509776","pubTimestamp":1764233028,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Pharmaron Beijing Co., Ltd. (stock code: 3759) has announced that its first Extraordinary General Meeting of 2025 will take place on Thursday, December 18, 2025 at 2:30 p.m., at 6 Tai-He Road,...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"03759":"康龙化成"},"translate_title":"康龙化成北京(3759)安排临时股东大会、寻求补选董事及修订管治政策","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"03759":1},"content_text":"Pharmaron Beijing Co., Ltd. (stock code: 3759) has announced that its first Extraordinary General Meeting of 2025 will take place on Thursday, December 18, 2025 at 2:30 p.m., at 6 Tai-He Road, Economic Technological Development Area, Beijing, the PRC.\nKey items to be addressed include a proposed by-election of an independent non-executive director to replace the outgoing incumbent. The board prepared multiple motions on amendments to governing documentation, including the Articles of Association, procedural rules for general and board meetings, and several internal management policies. Topics cover adjustments to related party/connected transactions management, external guarantees, investment oversight, and proceeds usage.\nThe agenda also includes updates to the rules on implementing the cumulative voting mechanism and clarifications to the procedure for shareholder nominations of director candidates. These changes aim to strengthen compliance with applicable regulatory requirements and refine the Company’s internal governance processes. Shareholders of record on December 15, 2025 will be entitled to vote. The final voting results will be published after the EGM. The Company’s board encourages shareholders to review the detailed proposals in preparation for the meeting.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,SGX","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1111509776","isCrawlerRequest":true}